Age-targeted chemotherapy for control of urinary schistosomiais in endemic populations
Severity of urinary tract morbidity increases with intensity and duration of Schistosoma haematobium infection. We assessed the ability of yearly drug therapy to control infection intensity and reduce S. haematobium-associated disease in children 5-21 years old in an endemic area of Kenya. In year I...
Main Authors: | Charles H. King, Eric M. Muchiri, John H. Ouma |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
1992-01-01
|
Series: | Memorias do Instituto Oswaldo Cruz |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000800031 |
Similar Items
-
Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya--Reply to Drs. Coles, Liang, and Doenhoff
by: C. H. King, et al.
Published: (2001-12-01) -
The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01) -
Urinary schistosomiasis in Nigeria: a 50 year review of prevalence, distribution and disease burden
by: Ezeh Charles Ogbonna, et al.
Published: (2019-01-01) -
Long-term outcomes of school-based treatment for control of urinary schistosomiasis: a review of experience in Coast Province, Kenya
by: Charles H King
Published: (2006-10-01) -
Urogenital schistosomiasis prevalence, knowledge, practices and compliance to MDA among school-age children in an endemic district, southern East Tanzania
by: Lilian C. Nazareth, et al.
Published: (2022-08-01)